As biologics, biosimilars and GLP-1s drive demand for sterile drug products, CMOs and CDMOs are investing in fill-finish, lyophilization, inspection and packaging capacity to keep pace with a dynamic ...

Strategies for integrated delivery networks (IDNs) to manage rising biologic medication costs while ensuring financial sustainability and patient outcomes are discussed during an interview with Elie M ...

Treatment for atopic dermatitis, the most common form of eczema, can vary from one person to another, because of factors like the frequency of flares and intensity of symptoms. Biologics, a class of ...

WASHINGTON - The Food and Drug Administration announced Wednesday that it plans to streamline the approval process for cheaper, "biosimilar" alternatives to biologic drugs in an effort to reduce ...

A West Virginia University legal scholar says current laws may be giving manufacturers of biologic drugs, like antibodies and flu vaccines, too much in the way of legal protections before copycat ...

Innovent Biologics has announced the inclusion of its drug Sintbilo (tafolecimab injection) and a new indication for Olverembatinib in China’s National Reimbursement Drug List for 2024, effective ...

It’s rare that terms such as “life changing,” “tremendous advance,” or “a difference of night and day” describe an evolving class of therapeutics without sounding like hyperbole. But in the case of ...

This collaboration offers an integrated solution for customers seeking to outsource the development and manufacturing of microbial and mammalian-expressed peptide drugs, with scalable options that ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative "biosimilar" versions of biologic drugs as a way to curb health costs. The ...